Mr Dimitrios Volanis

Consultant Urologist

MD, PHD, FEBU

Mr Volanis was appointed to the Royal Free London in 2015 having completed a fellowship at Cambridge in pelvic oncology and robotic surgery.

His special interest is bladder and prostate cancer. He is the bladder cancer lead and runs weekly clinics for newly diagnosed patients.

His research is focused on the molecular mechanisms that govern the development and progression of bladder cancer.

During his fellowship in Cambridge he worked in collaboration with Prostate Cancer UK investigating the incidence of needle tract seeding following prostate biopsy.

Throughout his career, Mr Volanis has been passionate and committed to high quality patient care putting patients’ needs as his central focus.

Specialities

  • Urology

Clinical interests

  • Bladder and prostate cancer
  • One stop haematuria and elevated PSA assessment
  • Benign bladder and prostate disorders
  • Penile and scrotal disorders
  • Recurrent urinary tract infections

Research interests

  • Novel urinary biomarkers in the diagnosis and follow-up of bladder cancer
  • Photodynamic diagnosis and chemoresection of bladder cancer
  • Role of MRI and template biopsy in investigation of elevated PSA, diagnosis of prostate cancer and follow up

Procedures Offered

  • Cystoscopy
  • TUR-P and TUR-BT
  • Transrectal and transperineal prostate biopsies
  • Circumcision and other penoscrotal surgery
  • Endoscopic urethral stricture management

Evolution and oncological outcomes of a contemporary radical prostatectomy practice in a UK tertiary referral centre. Gnanapragasam VJ, Thurtle D, Srinivasan A, Volanis DI, George A, Lothatananon A, Stearn S, Warren AY, Lamb AD, Shaw G, Sharma N, Thomas BC, Tran MG, Neal DE, Shah NC. BJU Int 2016 Nov;118(5):779-784

Evaluation of neutrophil gelatinase-associated lipocalin, interleukin-18 and cystatin C as molecular markers before and after unilateral shock wave lithotripsy. Kardakos IS, Volanis DI, Kalikaki A, Tzortzis VP, Serafetinides EN, Melekos MD, Delakas DS.Urology 2014 Oct;84(4):783-8

Incidence of needle-tract seeding following prostate biopsy for suspected cancer: a review of the literature. Volanis D, Neal DE, Warren AY, Gnanapragasam VJ.BJU Int. 2015 May;115(5):698-704

Comparative oncologic and toxicity outcomes of salvage prostatectomy versus non-surgical therapies for radio-recurrent prostate cancer: A meta-regression analysis. Philippou Y., Parker R., Volanis D.,GnanapragasamV.European Urology Focus (article in press)

Role of the angiogenic components VGEFA, FGF2, OPN and RHOC, in urothelial cell carcinoma of the urinary bladder. Zaravinos A, Volanis D, Lambrou GI, Delakas D, Spandidos DA. Oncol Rep. 2012 Oct;28(4):1159-66

Endoscopic Nephron-Sparing Management of Superficial Low-Grade Upper Urinary Tract Urothelial Carcinoma. Dimitrios Volanis, Ranan DasGupta, Anup Pate. European Urology Review, 2012;7(1):10-4

Expression of MiRNAs Involved in Angiogenesis, Tumor Cell Proliferation, Tumor Suppressor Inhibition, EMT and Activation of Metastasis in Urinary Bladder Cancer. Zaravinos A, Rodojicic J, Lambrou GI, Volanis D, Delakas D, Stathopoulos EN., Spandidos DA.J. Urol. 2012 Aug;188(2):615-23

Molecular mechanisms in urinary bladder carcinogenesis. Volanis D, Papadopoulos G, Gialas Ι, Doumas K, Delakas D. J BUON. 2011 Oct-Dec;16(4):589-601.

Expression profile of Rho kinases in urinary bladder cancer. Volanis D, Zaravinos A, Kadiyska T, Delakas D, Zoumpourlis V, Spandidos DA. J. BUON 2011 Jul-Sep; 16(3):511-521

Spotlight on differentially expressed genes in urinary bladder cancer. Zaravinos A, Labrou GI, Volanis D, Delakas D, Spandidos DA. PloS One. 2011 Apr 5;6(4):e18255

Plasmacytoid urothelial carcinoma of the bladder: a rare malignancy. Philippou P, Karyotis I, Volanis D, Ploumides A, Delakas D. Urol Int. 2011;86(3):370-2

Prospective comparative study of endoscopic management of bladder lithiasis: is prostate surgery a necessary adjunct? Philippou P, Volanis D, Karyotis I, Serafetinidis E, Delakas D. Urology. 2011 Jul;78(1):43-7

Safety of ultrasound-guided transrectal extended biopsy in patients receiving low-dose aspirin. Karyotis I, Philippou P, Volanis D, Serafetinidis E, Delakas D. Int Braz J Urol. 2010 May-Jun;36(3):308-16.

Environmental factors and genetic susceptibility promote urinary bladder cancer. Volanis D., Kadyiska T., Galanis A., Delakas D., Logotheti S., Zoumpourlis V.Toxicol Lett. 2010 15;193(2):131-7

Pheochromocytoma of the urinary bladder : Report of two cases and review of literature. Siatelis A., Konstantinidis C., Volanis D., Leontara V., Thoma-Tsagli E., Delakas D. Minerva Urol Nefrol 2008 Jun;60(2):137-140

Like to book an appointment?

Fill out the contact form below or call us on
020 7317 7751 to speak with a member of our team

020 7317 7751 Book a Consultation